Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression.
暂无分享,去创建一个
H. Moutsopoulos | E. Kapsogeorgou | M. Manoussakis | I. Dimitriou | R. Abu-Helu | H. M. Moutsopoulos | Rasmi F. Abu-Helu | Id Dimitriou | H. Moutsopoulos
[1] E. Kapsogeorgou,et al. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren's syndrome: high expression of intercellular adhesion molecule‐1 (ICAM.1) in biopsy specimens and cultured cells , 2001, Clinical and experimental immunology.
[2] Chulhee Choi,et al. Differential Regulation and Function of Fas Expression on Glial Cells1 , 2000, The Journal of Immunology.
[3] H. Moutsopoulos,et al. Sjögren's syndrome: autoimmune epithelitis. , 1994, Bailliere's best practice & research. Clinical rheumatology.
[4] A. Tzioufas,et al. Sjögren's syndrome. Autoimmune epithelitis. , 2000, Advances in experimental medicine and biology.
[5] M. Konopleva,et al. Apoptosis. Molecules and mechanisms. , 1999, Advances in experimental medicine and biology.
[6] C. Riccardi,et al. Glucocorticoid hormone-induced modulation of gene expression and regulation of T-cell death: role of GITR and GILZ, two dexamethasone-induced genes , 1999, Cell Death and Differentiation.
[7] J. Bonnefoy,et al. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. , 1999, Cytometry.
[8] K. Tsubota,et al. Preferential Localization of CD8+ αEβ7+ T Cells Around Acinar Epithelial Cells with Apoptosis in Patients with Sjögren’s Syndrome , 1999, The Journal of Immunology.
[9] K. Asadullah,et al. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. , 1999, Journal of immunology.
[10] M. Humphreys-Beher,et al. The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome , 1999, Clinical and experimental immunology.
[11] Y. Ahn,et al. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. , 1999, Journal of immunology.
[12] H. Moutsopoulos,et al. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. , 1999, Arthritis and rheumatism.
[13] F. Shanahan,et al. The Fas counterattack: cancer as a site of immune privilege. , 1999, Immunology today.
[14] R. Schlapbach,et al. TNF‐α and IFN‐γ render microglia sensitive to Fas ligand‐induced apoptosis by induction of Fas expression and down‐regulation of Bcl‐2 and Bcl‐xL , 1998 .
[15] Theocharis,et al. Modes of epithelial cell death and repair in Sjögren's syndrome (SS) , 1998, Clinical and experimental immunology.
[16] T. Sumida,et al. Glandular and extraglandular expression of the Fas-Fas ligand and apoptosis in patients with Sjögren's syndrome. , 1998, Clinical and experimental rheumatology.
[17] P. Fox,et al. Fas and Fas-mediated effects on a human salivary cell line in vitro: a model for immune-mediated exocrine damage in Sjögren's syndrome , 1998, Cell Death and Differentiation.
[18] R. Maria,et al. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. , 1998, Immunology today.
[19] T. Ochi,et al. Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing , 1997, The Journal of experimental medicine.
[20] C. Riccardi,et al. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. , 1997, Immunity.
[21] G. Rosen,et al. Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-γ and Fas. , 1997, American journal of physiology. Lung cellular and molecular physiology.
[22] P. Walker,et al. Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. , 1997, Journal of immunology.
[23] J. Polak,et al. Role of nitric oxide in Sjögren's syndrome. , 1997, Arthritis and rheumatism.
[24] M. Todaro,et al. Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis , 1997, Science.
[25] U. Boehm,et al. Cellular responses to interferon-gamma. , 1997, Annual review of immunology.
[26] N. Ogawa,et al. Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome. , 1997, Arthritis and rheumatism.
[27] K. Koretz,et al. Early detachment of colon carcinoma cells during CD95(APO-1/Fas)- mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44 , 1996, The Journal of cell biology.
[28] F. Ramsdell,et al. Fas and FasL in the homeostatic regulation of immune responses. , 1995, Immunology today.
[29] D. Green,et al. Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.
[30] D. Green,et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.
[31] M. Weller,et al. CD95 (Fas/APO-1) antibody-mediated apoptosis of human retinal pigment epithelial cells. , 1995, Biochemical and biophysical research communications.
[32] S. Nagata,et al. The Fas death factor , 1995, Science.
[33] S. Nagata,et al. Fas and Fas ligand: lpr and gld mutations. , 1995, Immunology today.
[34] S. Yonehara,et al. Involvement of apoptosis antigen Fas in clonal deletion of human thymocytes. , 1994, International immunology.
[35] S. Nagata,et al. Fas-mediated apoptosis in primary cultured mouse hepatocytes. , 1994, Experimental cell research.
[36] B. Baum,et al. Effect of tumor necrosis factor‐α and interferon‐γ on the growth of a human salivary gland cell line , 1994, Journal of cellular physiology.
[37] J. Abrams,et al. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. , 1994, Journal of immunology.
[38] S. Ju,et al. Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Frisch,et al. Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.
[40] D. Isenberg,et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. , 1993, Arthritis and rheumatism.
[41] K. Bendtzen,et al. Cytokine expression in labial salivary glands from patients with primary Sjögren's syndrome. , 1992, Autoimmunity.
[42] M. Merćep,et al. Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. , 1990, Journal of immunology.
[43] A. Drosos,et al. Labial salivary gland immunopathology in Sjögren's syndrome. , 1986, Scandinavian journal of rheumatology. Supplement.
[44] J. Cohen,et al. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. , 1984, Journal of immunology.